#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma Pleomorphic liposarcoma Dermatitis Lupus nephritis Pleural mesothelioma Hereditary hypophosphataemic rickets Mucous membrane pemphigoid Chronic myelomonocytic leukaemia Hypophosphatasia Renal cancer metastatic Restless legs syndrome Post transplant lymphoproliferative disorder Infection in an immunocompromised host Chondrodystrophy IPEX syndrome More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Diagnostics Mucopolysaccharidosis III – Trials in Disease Uterine leiomyosarcoma – Basic Information Cystic fibrosis – Life with Disease Mitochondrial myopathy – Treatment Hairy cell leukaemia – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Mucous membrane pemphigoid X-linked lymphoproliferative syndrome – Diagnostics Angiosarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANHYDROUS CALCIUM FOLINATE Glutathione Anhydrous Cidofovir Loperamide Hydrochloride Retifanlimab Buprenorphine Peginterferon Beta-1A Tapderimotide 2,4 DICHLOROBENZYL ALCOHOL Oxygen Sisunatovir Caffeine Citrate Vesleteplirsen Menotrophin Cytisinicline Deucrictibant Vb10.16 RIKKUNSHITO 534 Sabirnetug More therapies…

    Learn about Your Condition

    Post procedural swelling Anorexia nervosa Penile squamous cell carcinoma Meniscus injury Papillary thyroid cancer Chronic hepatic failure Abortion threatened Ventricular fibrillation Cortisol abnormal Osteomyelitis Malignant melanoma stage II Hepatobiliary cancer Obesity Pleural mesothelioma Breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Acute lymphocytic leukaemia

  • Study of Blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Asparaginase
    • Blinatumomab
    • Crisantaspase
    Austria Belgium Bulgaria Czechia Denmark Estonia +11

  • Study of TranspoCART19 cell therapy for patients with CD19-positive acute lymphoblastic leukemia that is resistant or refractory to treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Transpocart19
    Spain

  • Study of olverembatinib with chemotherapy versus standard therapy in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Philadelphia positive acute lymphocytic leukaemia
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • OLVEREMBATINIB
    • Imatinib Mesilate
    • Ponatinib
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study of TdT-3 cell therapy safety in patients aged 1 year and older with relapsed or refractory acute leukemia or lymphoblastic lymphoma

    Recruiting

    2 1 1
    Norway

  • Study on MB-CART2219.1 for Adults and Children with Relapsed or Refractory B-cell Malignancies

    Recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • MB-CART2219.1
    Germany

  • Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients 55+ with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Ponatinib
    • Blinatumomab
    • Imatinib
    Finland France Sweden
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!